Overview

AVODART(Dutasteride) Post-marketing Surveillance(PMS)

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of AVODART administered in Korean BPH patients according to the prescribing information
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Dutasteride